Flurbiprofen Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Flurbiprofen Market will grow significantly in the forecasted period 2021 to 2027.

Flurbiprofen, a derivative of propionic acid, is a non-steroidal anti-inflammatory drug (NSAIA) with antipyretic and analgesic activity. Oral formulations of flurbiprofen can be used for symptomatic treatment of rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. Flurbiprofen may also be used topically prior to ophthalmic surgery to prevent or reduce miosis during surgery. Flurbiprofen is structurally and pharmacologically related to fenoprofen, ibuprofen and ketoprofen.

Market Segments

By application:

• Nonsteroidal Anti-Inflammatory Drugs
• Topical Administration for Joint And Muscle Pain
• Soft Tissue Disease
• Dysmenorrhea
• Post-Operative Pain
• Toothache
• Other

By product type:

• Injection
• Patch
• Tablet

Key Players

• Mylan Pharmaceuticals
• Tokuhon
• Recordati
• Mikasa Seiyaku
• Bausch Health
• Pfizer
• Abbott
• Allergan

Scope of the Report

The research study analyzes the global Flurbiprofen industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Flurbiprofen Market Report

1. What was the Flurbiprofen Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Flurbiprofen Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Flurbiprofen Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.